Health Care & Life Sciences » Biotechnology | GeneOneLifeScience Inc.

GeneOneLifeScience Inc.

GeneOneLifeScience Inc.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW444.89
Market Cap
KRW93.42 B
Shares Outstanding
21.19 M
Public Float
18.38 M

Profile

Address
Unit 1903, Keungil Tower
Seoul SL 06142
Korea, Republic Of
Employees -
Website http://www.genels.com
Updated 07/08/2019
GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluprime. Its service include process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others.

Financials

View All

Young-Geun Park
Chief Executive Officer & Director
Byung-Moon Cho
Senior Managing Director & Head-Domestic